What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study


Onal I. K. , Gokcan H., Benzer E., Bilir G., Oztas E.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.37, sa.6, ss.642-646, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Konu: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.clinre.2013.05.005
  • Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
  • Sayfa Sayıları: ss.642-646

Özet

Background and objective: To investigate the presence of any possible association between H. pylori density in the stomach and the efficacy of triple (lansoprazole 30mg b.i.d., clarithromycin 500mg b.i.d. and amoxicillin 1g b.i.d. for 14 days) and bismuth-containing quadruple (colloidal bismuth subcitrate 300mg q.i.d., lansoprazole 30mg b.i.d., tetracycline 500mg q.i.d. and metronidazole 500mg t.i.d. for 14 days) eradication therapies.